Hybridoma Cell Line 25-D1.16 Producing Monoclonal Anti-H-2Kb/SIINFEKL Complex Antibody

An H-2Kb/OVA hybridoma cell line producing a monoclonal antibody specific for the H-2Kb/SIINFEKL complex (clone 25-D1.16) as described in Immunity 1997 Jun;6(6):715-26 and developed in the laboratory of Dr. Ronald Germain at the National Institute of Allergy and Infectious Diseases.

Potential Commercial Applications: Competitive Advantages:
  • A research material that can be used in the development of assays, validation of products or in quality control.
  • Speed up product development with NIH developed material that has already been tested and validated.


Ronald Germain (NIAID)  ➽ more inventions...

Angel Porgador (NIAID)  ➽ more inventions...

Intellectual Property:
Research Material – Patent protection is not being pursued for this technology. (IC Reference No. 1948-011)

Porgador A, et al. PMID 9208844

Licensing Contact:
Daniel Lee, J.D.
Email: daniel.lee5@nih.gov
Phone: 301-761-6327

OTT Reference No: B-006-1999-0
Updated: Dec 4, 2017